Blog Full Right Sidebar

Infosys is set to launch its Rs 18,000-crore share buyback on November 20, closing on November 26. The buyback allows the IT giant to repurchase up to 10 crore shares at Rs 1,800 each via the tender offer route. Shareholders as of the record date, November 14, are eligible. Kotak Mahindra Capital manages the issue, with KFin Technologies as registrar.Read More

US equity markets are experiencing a long-overdue correction, impacting global flows into Asia. While India’s fundamentals remain strong, foreign investor sentiment is shifting. Market expert Rahul Arora advises caution on consumer staples, favoring discretionary names and highlighting banking and financials as key investment opportunities.Read More

Public sector banks are rallying, sparking debate on their valuations compared to private lenders. Rahul Arora sees opportunities, especially in SBI and Bank of Baroda. He notes a significant valuation gap remains, suggesting further upside potential for PSU banks. Private banks face growth limitations due to large balance sheets. Global fund flows could favor banks if capital returns to India.Read More

Sudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS. The price band for the offer is set at Rs 563–593, with 50% of shares reserved for QIBs, 15% for NIIs and 35% for retail investors. With a GMP hovering around 16% ahead of the launch, the IPO is generating significant buzz...Read More

Capillary Technologies India is set to finalise share allotment for its ₹877.5 crore IPO today. Applicants can view their allotment status on the BSE website or the registrar MUFG Intime India’s portal once the process is completed. The company’s shares are slated to list on November 21.Read More